skip to Main Content

FibriCheck is ready to enter the U.S. market with FDA-clearance!

After a rigorous investigation procedure by the Food and Drug Administration, FibriCheck is now FDA-cleared (K232804). This is an important milestone which supports our further development in the U.S. market. The FDA-clearance allows us to improve current U.S. care pathways…

FibriCheck’s 2023 wrap-up

At FibriCheck, we are always innovating and working towards improved efficiency and innovation in heart healthcare. This year, we’ve made important strides towards those goals, as we worked on a variety of interesting projects together with our partners, and made…

Artificial intelligence in healthcare

Artificial intelligence is becoming increasingly important in all sectors, as it is a growing field with new possibilities emerging every day. As AI algorithms and technologies become more advanced, they can be implemented to optimise processes, make predictions, and provide…

Qompium announces the spin-off of its Extra Horizon business

Hasselt, Sep 30, 2022 - Extra Horizon, a leader in the Medical Backend-as-a-Service (MBaaS) market, has officially demerged from its parent company, Qompium nv. For almost a decade now, Qompium has been a leading pioneer in the Software as a…

Navigating the digital pathway in the NHS with DigitalHealth.London

Our acceptance into DigitalHealth.London’s Accelerator programme, gave us the opportunity to significantly increase our credibility and visibility with NHS stakeholders. At the same time, we also grew our understanding of UK Information Governance (IG) and cyber security requirements.

FibriCheck’s pulse beating stronger than ever in 2021

We started 2021 off strong with a new investment round. The newly invested 9 million euros allowed us to further accelerate the growth of both our business units. While keeping one eye on international growth, the FibriCheck app is also…

9 million euros in funding for eHealth pioneer Qompium

Hasselt, February 3, 2021 - Qompium, the pioneering Belgian digital health company, has received an additional 9 million euros in funding after a new capital round. With its business units FibriCheck (medical app which detects heart rhythm disorders) and Extra Horizon (secure,…

2020: a year of challenges and triumphs for FibriCheck

It’s been an exciting year for FibriCheck! And looking back at everything we achieved together with our partners in 2020, it’s remarkable how many milestones we have reached and surpassed. Read on for a brief overview of the year that…

Back To Top
Search